Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: SRI INTERNATIONAL
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-01 to 2026-01-31
Current total value of award: $49150.11
Description: NICHD: R&D: ANDROGENIC, ANABOLIC, AND PRECLINICAL SAFETY STUDIES: NON-SEVERABLE